Citation Impact
Citing Papers
MRS in presymptomatic MAPT mutation carriers
2010
Classification of primary progressive aphasia and its variants
2011 Standout
Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations
1999
DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task
2000 StandoutNobel
Parkinson disease
2017 Standout
Phenotypic presentation of frontotemporal dementia with Parkinsonism‐chromosome 17 type P301S in a patient of Jewish‐Algerian origin
2003
The detection of preclinical Parkinson's disease: What is the role of positron emission tomography?
1993
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Localization of the Gene for Rapidly Progressive Autosomal Dominant Parkinsonism and Dementia with Pallido-Ponto-Nigral Degeneration to Chromosome 17q21
1996
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
1999
Neurocognitive Consequences of Sleep Deprivation
2009 Standout
The role of nuclear medicine in infection and inflammation
2001
Bruxism physiology and pathology: an overview for clinicians*
2008 Standout
A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
1999
Neuroimaging in sleep medicine
2007
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Phenotypic variation in hereditary frontotemporal dementia with tau mutations
1999
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study
2015
Parkinson's disease: clinical features and diagnosis
2008 Standout
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
2000 Standout
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies
1998
Clinical genetic analysis of Parkinson's disease in the contursi kindred
1996
Cell division in the CNS: Protective response or lethal event in post-mitotic neurons?
2006
Epidemiology of Parkinson's disease
2006 Standout
The genetics and neuropathology of Parkinson’s disease
2012
Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog
2008 Standout
Dementia of Frontal Type and Dementias with Subcortical Gliosis
1998
In vivo imaging of synaptic function in the central nervous system
2009
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
2007 Standout
Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
2004
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Does Ultra-Low-Dose CT With a Radiation Dose Equivalent to That of KUB Suffice to Detect Renal and Ureteral Calculi?
2005
Epidemiology of Parkinson’s disease
2017 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
2003
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy
2007
Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations
2007
Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease
2000
Alzheimer's Disease
2010 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Transmembrane Signalling Systems in the Brain of Patients with Parkinson's Disease
1993
Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy
2004
Non-motor features of Parkinson disease
2017 Standout
A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
1999
From genotype to phenotype: A clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
1999
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
2000 Standout
Surgery for Seizures
1996 Standout
Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient
1995
Segregation of a Missense Mutation in the Microtubule-Associated Protein Tau Gene with Familial Frontotemporal Dementia and Parkinsonism
1998
The Relative Contributions of MRI, SPECT, and PET Imaging in Epilepsy
1994
Hereditary frontotemporal dementia is linked to chromosome 17q21—q22: A genetic and clinicopathological study of three dutch families
1997
Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson’s Disease
2003
Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms
1998
Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study
2006
Subcutaneous Apomorphine
2004
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
A systematic review of prevalence studies of dementia in Parkinson's disease
2005 Standout
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis
2015 Standout
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
1997
False-negative abdominal CT scan in a cocaine body stuffer
1999
Systematic analysis of gene expression in human brains before and after death
2005 StandoutNobel
A comparison of patient dose for examinations of the upper gastrointestinal tract at 11 conventional and digital X-ray units in The Netherlands.
1998
Familial Multiple-System Tauopathy with Presenile Dementia Is Localized to Chromosome 17
1997
The diagnosis of Parkinson's disease
2005
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
2003 Standout
The molecular pathology of Alzheimer's disease
1991 Standout
Epidemiology of Bruxism in Adults: A Systematic Review of the Literature
2013 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Gut Microbiota in Health and Disease
2010 Standout
Management of ingested foreign bodies and food impactions
2011 Standout
Neurodegenerative Tauopathies
2001 Standout
Guideline for the management of ingested foreign bodies
2002 Standout
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
2000
Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors.
1993
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Molecular Characterization of Human and Rat RGS 9L, a Novel Splice Variant Enriched in Dopamine Target Regions, and Chromosomal Localization of the RGS 9 Gene
1998
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Familial parkinsonism, dementia, and lewy body disease: Study of family G
1997
Autism and clostridium tetani
1998
A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation
2000
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
1998
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
1999
The prevalence of Parkinson's disease: A systematic review and meta‐analysis
2014 Standout
Computerized Tomography: An Unreliable Method for Accurate Staging of Bladder Tumors in Patients who are Candidates for Radical Cystectomy
1989
Rotenone, Paraquat, and Parkinson’s Disease
2011 Standout
Works of M. Cordes being referenced
Bestimmung der zerebralen Dopamin–(D2)–Rezeptoren–Dichte mit Hilfe der123Jod–IBZM–SPECT bei Patienten mit Morbus Parkinson
1992
Graves ophthalmopathy: MR imaging of the orbits.
1989
Correlation of clinical response in apomorphine test with D2‐receptor status as demonstrated by 123I IBZM‐SPECT
1993
Drug smuggling by ingested cocaine-filled packages: conventional x-ray and ultrasound
1995
Increased rCBF in gray matter heterotopias detected by SPECT using99mTc hexamethyl-propylenamine oxime
1991
Parametric imaging of the rate constant Ki using [18Fluoro]-l-dopa positron emission tomography in progressive supranuclear palsy
1993
Age‐dependent decline of nigrostriatal dopaminergic function: A positron emission tomographic study of grandparents and their grandchildren
1994
Regression of Left Ventricular Hypertrophy Under Ramipril Treatment Investigated by Nuclear Magnetic Resonance Imaging
1989
Dystonis in ataxia telangiectasia: Report of a case with putaminal lesions and decreased striatal [123I]Iodobenzamide Binding
1994
Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease
1991
Single‐photon Emission Computed Tomography Investigations of Alternating Hemiplegia of Childhood
1993
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration
1992
Focal Epilepsies
1990
IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls.
1993
[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
1992
Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
1994
Iodine-123-iodo-lisuride SPECT in Parkinson's disease.
1996
Vascular Graft Infection: Detection by 123I-Labeled Antigranulocyte Antibody (Anti-NCA95) Scintigraphy
1991
Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
1998
Prostatakarzinom
1987
[Estimating patient dosage in radiologic examinations. Effective doses of the most frequent roentgen examinations].
1995
[Brain SPECT with 123I-lisuride in patients with Parkinson's disease and controls].
1995
L-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion
1992